The seed round was led by Par Equity with backing from Northern Gritstone and the GMC Life Sciences Fund By Praetura.
Re:course AI develops a conversational digital human platform that acts as a virtual medical simulator for healthcare training. The technology provides realistic patient interactions and automated feedback for doctors, nurses and students.
Re:course AI has secured £3.5m in seed funding to expand its engineering team and scale its operations. The investment was led by Par Equity, with additional participation from Northern Gritstone, the GMC Life Sciences Fund By Praetura, and private backers including Rob Wood and the founders of Current Health. The Manchester-based company builds conversational AI digital human avatars designed to simulate patient interactions for medical training.
From the founder
"The aviation industry is another sector where safety is of paramount importance, and it has led the way in demonstrating the value of simulated training to maintain and update the skills of pilots,"
Scott Martin
CEO at Re:course AI
Investor perspective
"Re:course AI has the potential to disrupt how the healthcare professionals of the future are trained, as the demand for virtual AI-based training is growing,"

Aidan MacMillan
Senior Investment Manager, Par Equity
Use of funds
- 01Grow the team
- 02Expand into international markets
Investors

Aidan MacMillan
Par Equity
Duncan Johnson
Northern Gritstone
Sim Singh-Landa
GMC Life Sciences Fund By Praetura
Categories
About the company
Re:course AI
Re:course AI builds a virtual training simulator for healthcare and life sciences.